Infinitus Launches FieldForce AI Agents for Pharmaceutical Teams

Oct 7, 2026
FieldForce provides AI agents that support pharmaceutical sales and reimbursement teams before, after and between meetings with healthcare providers.

Infinitus Systems, Inc. introduced FieldForce, a set of secure AI agents for pharmaceutical sales and reimbursement teams, in a press release. The agents help staff prepare for meetings with healthcare providers, record notes, update customer relationship management systems and answer provider questions between visits.

For field reimbursement managers, FieldForce can handle questions about prior authorization status, claims and reimbursement. Other agents can receive inbound calls at any time, while Infinitus Lens monitors communications for compliance and identifies prescribing trends and common support topics.

FieldForce separates promotional and medical communications. If a provider asks a clinical or safety question outside a sales representative's role, the system can transfer the conversation and its context to the pharmaceutical company's medical information team.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly, Sales & Marketing AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.